Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Medibank Private Limited
  6. Summary
    MPL   AU000000MPL3

MEDIBANK PRIVATE LIMITED

(MPL)
  Report
Delayed Quote. Delayed Australian Stock Exchange - 01/25 12:10:13 am
3.14 AUD   -2.48%
01/20MEDIBANK PRIVATE : Healthcare trends and innovations 2022 and beyond
PU
2021MEDIBANK PRIVATE : The moments that made 2021
PU
2021MEDIBANK PRIVATE : Notification regarding unquoted securities - MPL
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Australian Stock Exchange
01/19/2022 01/20/2022 01/21/2022 01/24/2022 01/25/2022 Date
3.39(c) 3.28(c) 3.26(c) 3.22(c) 3.14(c) Last
5 492 012 10 632 377 6 547 607 4 483 696 8 424 083 Volume
-0.59% -3.24% -0.61% -1.23% -2.48% Change
More quotes
Estimated financial data (e)
Sales 2022 7 281 M 5 221 M 5 221 M
Net income 2022 432 M 310 M 310 M
Net cash position 2022 2 181 M 1 564 M 1 564 M
P/E ratio 2022 20,1x
Yield 2022 4,12%
Sales 2023 7 671 M 5 501 M 5 501 M
Net income 2023 455 M 326 M 326 M
Net cash position 2023 2 289 M 1 642 M 1 642 M
P/E ratio 2023 19,0x
Yield 2023 4,35%
Capitalization 8 650 M 6 178 M 6 203 M
EV / Sales 2022 0,89x
EV / Sales 2023 0,83x
Nbr of Employees 3 409
Free-Float 99,4%
More Financials
Company
Medibank Private Ltd is an Australia-based health insurance company. The Company operates through two segments: Health Insurance and Medibank Health. Health Insurance segment offers private health insurance products, including hospital cover and ancillary cover, as stand-alone products or packaged products that combine the two. Hospital cover provides members with health cover for hospital treatments, whereas... 
Sector
Life & Health Insurance
Calendar
02/24 | 05:30pmEarnings Call
More about the company
Ratings of Medibank Private Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about MEDIBANK PRIVATE LIMITED
01/20MEDIBANK PRIVATE : Healthcare trends and innovations 2022 and beyond
PU
2021MEDIBANK PRIVATE : The moments that made 2021
PU
2021MEDIBANK PRIVATE : Notification regarding unquoted securities - MPL
PU
2021MEDIBANK PRIVATE : Weight loss and exercise helping to manage osteoarthritis
PU
2021MEDIBANK PRIVATE : Results of AGM (PDF - 177 KB)
PU
2021MEDIBANK PRIVATE : Chairman and Chief Executive Officer AGM Presentations
PU
2021MEDIBANK PRIVATE : Chairman and CEO presentations (PDF - 281 KB)
PU
2021Rewarding Australians for taking preventative health actions
PU
2021Build your own extras to support your health needs
PU
2021Excitement sky high ahead of travel resuming
PU
2021MEDIBANK PRIVATE : Lockdowns are ending, but the impacts are not
PU
2021Scientific Games cuts proposed Australian IPO of unit to $3 bln -sources
RE
2021MEDIBANK PRIVATE : introduces COVID vaccination requirement for employees
PU
2021MEDIBANK PRIVATE : 450,000 reasons to say thanks
PU
2021NIB : Honeysuckle Health, nib buying group authorised with condition
AQ
More news
News in other languages on MEDIBANK PRIVATE LIMITED
2021Medibank Private affiche un bénéfice et des revenus plus élevés pour l'exercice 21
2021Medibank Private Limited fournit des prévisions de bénéfices pour 2022
2021Medibank Private Limited annonce une distribution ordinaire entièrement libérée pour le..
2021Medibank Private va restituer à ses clients 79 millions de dollars d'économies réalisée..
2021Medibank Private nomme un nouveau PDG
More news
Chart MEDIBANK PRIVATE LIMITED
Duration : Period :
Medibank Private Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDIBANK PRIVATE LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Last Close Price 3,14 AUD
Average target price 3,60 AUD
Spread / Average Target 14,8%
EPS Revisions
Managers and Directors
David Koczkar Chief Executive Officer & Managing Director
Mark Rogers Chief Financial Officer & Group Strategy Officer
Michael Wilkins Chairman
John Goodall Group Executive-Technology & Operations
Anna Bligh Independent Non-Executive Director
Sector and Competitors